The global butterfly needle sets market size was valued at USD 221.32 million in 2022. It is expected to reach USD 453.6 million by 2030, growing at a CAGR of 8.30% during the forecast period (2023–2031).
Winged infusion sets and scalp vein sets are additional names for butterfly needle sets. These sets are utilized for IV rehydration, drug infusions, and blood extraction from veins. Butterfly needles are used more frequently for blood transfusions than alternative items because they are less expensive, more efficient, and more painful than those alternatives. Butterfly needles provide advantages to straight needles, including the ability to be placed more precisely, especially in difficult-to-access veins. A hypodermic needle, two flexible wings on either side and a connector are all included in butterfly needle sets, which take blood from an infusion pump using a vacuum tube or collecting bag.
Butterfly needles are in high demand due to the rise in chronic diseases like bleeding disorders, cardiovascular disorders, cancer, and intravenous therapy. This has led to an upsurge in the use of butterfly needles for blood collection. For instance, the World Federation of Hemophilia estimates that 210,454 people worldwide were diagnosed with hemophilia in 2018 and 78,500 with von Willebrand disease. Additionally, the current rise in cancer and other fatal diseases has resulted in the widespread use of intravenous therapy, cancer treatments, and blood transfusions. Due to the increased use of butterfly needles for administering chemotherapy fluids and medication fluids, the market for butterfly needle sets is growing.
Butterfly needles are easy and precise for patients with small veins due to their shorter length and fragile qualities, which make inserting them into delicate veins easier. Winged-infusion blood collection needles are also the best option for patients with small or delicate veins, including neonatal/pediatric, geriatric, oncology, and burn injury patients. Common butterfly needles also come in various gauges and are 1/2 to 3/4 inches long, with the most popular gauges being 21 and 23 gauge. The smallest gauge, 25 to 27, is typically used for pediatric patients.
Phlebotomists can more easily install needles on patients thanks to the short needle's length, which enables them to insert it at a shallow angle. A safety feature that slides over the needle after use to lock it reduces the risk of needle stick injuries in the butterfly needle blood collection set. In addition, a 2013 study by Academic Emergency Medicine found that using butterfly needles rather than an intravenous catheter significantly reduces hemolysis. As a result, the above factors make it easier to use butterfly needles, which helps the market grow.
The most suitable patients for employing butterfly needles are those with tiny, tremor-prone veins. They are employed in numerous other processes, such as administering IV infusions and medications to patients. No further developments have been noticed in the market product launch and approval in the past few years due to the 65% lower needlestick injuries (NSI) (caused by needles that unintentionally puncture the skin) compared to alternatives. Consequently, there have not been any product innovations for butterfly needles. They also prefer highly developed needles, such as push-button blood collection systems, due to NSI. The market growth is hampered by the lack of pipeline studies from recent years on the use of butterfly needles in treating pediatric/neonatal patients.
Butterfly needles’ benefits lead to expectations of expanding market opportunities for butterfly needles in various applications. These needles make accessing small or narrow veins less painful, like those in infants or the elderly. Furthermore, they are less likely to result in severe bleeding, nerve damage, or vein collapse once removed. A slide-and-lock sheath is another feature of more recent models that automatically slides over the needle as it is extracted from a vein, reducing the risk of needlestick injuries and avoiding the need for additional needles. As a result of these advantages, the market for butterfly needle sets is likely to grow due to the adoption of these devices.
| Study Period | 2018-2030 | CAGR | 8.30% |
| Historical Period | 2018-2020 | Forecast Period | 2022-2030 |
| Base Year | 2021 | Base Year Market Size | USD 221.32 Million |
| Forecast Year | 2030 | Forecast Year Market Size | USD 453.6 Million |
| Largest Market | Asia Pacific | Fastest Growing Market | North America |
By Region, the global butterfly needle sets market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
Asia-Pacific is the most significant contributor to the global butterfly needle sets market and is expected to grow at a CAGR of 9.4% during the forecast period. India, China, Japan, Australia, South Korea, and the rest of Asia-Pacific are among the nations represented in the Asia-Pacific butterfly needle set market. The butterfly needle set market is the largest and quickly expanding in Asia-Pacific. Due to the vast untapped potential in this area, it is the most lucrative market. It is anticipated that the rising purchasing power of populous nations like China and Japan will accelerate the expansion of the Asia-Pacific butterfly needle set market. In addition, factors like the rise in blood donation clinics in this region due to population growth and the development of the Thalassemic, Hemophilic, and cancer patient pools contribute to the market's expansion. Furthermore, the market growth is anticipated to be fueled by significant key players like B. Braun Melsungen AG, ISOMed, BioMatrix S.r.l., Nipro Corporation, and Kawasumi Laboratories, Inc.
North America is expected to grow at a CAGR of 7.80% during the forecast period. In 2021, North America was the second-highest revenue-producing region. The most common chronic diseases for which butterfly needles are used are bleeding disorders and cancer. The U.S. leads the market for butterfly needle sets in North America, followed by Canada. In addition, leading U.S. industry participants like Becton, Dickinson and Company, Cardinal Health, Inc., Greiner Bio-One North America, Inc., Medline Industries, Inc., JMS North America Corporation, and Terumo Corporation are responsible for the. In 2018, 17,757 Americans received a hemophilia diagnosis. A genetic blood disorder called hemophilia impairs blood clotting's normal functionality. The market for butterfly needle sets is also growing due to blood collection regulations and clinical trial usage.
Europe is expected to grow significantly over the forecast period. The market for butterfly needle sets in Europe is anticipated to grow due to increasing attention paid to hemolysis in clinical trials and an increase in chronic diseases. More than one million needle stick injuries occur annually in Europe, which prompted the establishment of government regulations to decrease these injuries in 2013. Additionally, newborns are being treated for symptomatic pneumothorax with needle aspiration (NA) and chest drain (CD) insertion, thanks to clinical trials conducted in 2018 in European neonatal intensive care units on newborns. Thus, the above factors contribute to the market's expansion.
Brazil, South Africa, Saudi Arabia, and the rest of LAMEA are among the nations considered in this region. The butterfly needle set market is the least active in LAMEA. However, the market is anticipated to grow due to untapped opportunities, such as many people with chronic diseases, the aging population, and inadequate healthcare facilities. Due to the rising geriatric population and the high prevalence of chronic diseases that necessitate butterfly needles in this area, penetration of butterfly needles is anticipated to experience steady demand in the future. As a result, the market for butterfly needle sets is expected to grow due to the rise in the number of people who require them.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global butterfly needle sets market is segmented by application and end-user.
Based on the application, the global market is bifurcated into blood transfusion, venipuncture, IV rehydration, and delivery of medications.
The blood transfusion segment is the highest contributor to the market and is expected to grow at a CAGR of 8.7% during the forecast period. Giving a sick patient an intravenous blood transfusion involves giving healthy people blood or blood products like platelets, albumin, cryoprecipitate, and plasma. Patients with bleeding disorders like hemophilia or von Willebrand disease benefit from the butterfly needle. Large-sized butterfly needle gauges with vacuum systems are needed to collect blood for transfusions. Additionally, numerous combinations of butterfly needles for blood transfusion are available, including single-use/disposable, sterile, and winged needles attached to flexible tubing with a luer connector.
Several businesses, including SOL-Millennium, Zibo Econst Medical Instrument Co Ltd, Perfect Medical Industry Co., Ltd., and Smiths Medical, also provide butterfly needles on a global scale. A study published in Academic Emergency Medicine in 2016 found that drawing blood with butterfly needles reduced the rate of red blood cell destruction by half compared to drawing blood with IV catheter needles. Therefore, these factors contribute to the market's growth.
The venipuncture procedure is used to gain intravenous access for blood sampling or intravenous therapy. A winged infusion set, also referred to as a butterfly or scalp vein set is a tool used in venipuncture for phlebotomy, the procedure of inserting a cannula into a vein to puncture it to draw blood. Phlebotomists, medical professionals who specialize in drawing blood, draw blood primarily by performing venipunctures, but they can also draw blood with butterfly needles. A hypodermic needle, two flexible bilateral wings, and flexible small-bore transparent tubing with 21G (gauge) or smaller needles are required for the venipuncture procedure. The flexible tubing in the butterfly wings allows flexibility to reach various body surfaces. It offers patient movement tolerance, making venipuncture of the hand and leg's superficial veins easier. Additionally, venipuncture is the preferred technique for drawing blood from newborns because it is quicker, less painful, and associated with less anxiety in the mother.
Based on the end-user, the global market is bifurcated into hospitals and blood banks.
The hospital segment owns the highest market share and is anticipated to grow at a CAGR of 8.3% during the forecast period. A hospital is a place of health care that offers patient care using specialized medical and nursing staff and medical supplies. To collect blood for diagnostic tests like the complete blood count (CBC), cholesterol tests, diabetes monitoring, and STD screening, pathology departments in hospitals use butterfly needles to prick the patients' veins. Additionally, because butterfly needles are flexible, thin, and painless, they are preferred during surgery for patients with cancer, HIV, and hemophilia. They are on critical care, intravascular treatments, and cardiovascular surgeries.
A blood bank is a location where people can donate blood and have their blood collected, stored, and used to help those in need. People who want to donate blood frequently use butterfly needles at blood banks, especially those whose veins are small and spastic. The American Association of Blood Banks (AABB) Standards in 2014 for Blood Banks and Transfusion Services also state that platelet apheresis donor blood can only be drawn 24 times in a rolling 12-month period, or a maximum of two times per week. There should be at least two days between the two collections. To prevent excessive donor platelet and plasma loss, the Food and Drug Administration (FDA) mandated these guidelines for the industry. However, new regulations enable donors to give blood more frequently. According to the American National Red Cross, 6.8 million Americans donate blood annually.
